A large amount of new clinical data has emerged which demonstrates the potential to substantially improve both semen and ovarian reserve assessments through the first evaluation of the infertile couple.
The potential for establishing consensus regarding diagnostic algorithms will be discussed in the context of reviewing the latest clinical data assessing newer diagnostics, such as anti Mullerian Hormone (AMH) and new algorithmic approaches, as well as older, controversial diagnostics such as sperm DNA fragmentation.
Data will be examined that demonstrates the improvement in ART success that is possible with appropriate incorporation of gynecology and urology into the clinical algorithms of fertility care.
Finally, proposed new technologies will be evaluated in the context of the successes and failures of diagnostics introduced in the past with the intent of learning from history. |